High relaxivity linear Gd(DTPA)‐polymer conjugates: The role of hydrophobic interactions

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Magnetic Resonance in Medicine

• Publication date

  1997-11-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/mrm.1910380506PMID 9358444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relaxation of solvent protons by solute Gd3+‐chelates, revisited

  1997cited by this paper
• Water-exchange, electronic relaxation, and rotational dynamics of the MRI contrast agent [Gd(DTPA-BMA)(H2O)] in aqueous solution: a variable pressure, temperature, and magnetic field oxygen-17 NMR study

  1994cited by this paper
• Micellization of poly(ethylene oxide)-poly(propylene oxide) block copolymer in aqueous solution : effect of polymer impurities

  1994cited by this paper
• Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents

  1994cited by this paper
• Temperature-dependent micellization in aqueous block copolymer solutions

  1992cited by this paper
• Proton relaxation enhancement by means of serum albumin and poly-L-lysine labeled with DTPA-Gd3+: relaxivities as a function of molecular weight and conjugation efficiency.

  1992cited by this paper
• Self-assembly in aqueous block copolymer solutions

  1992cited by this paper
• Evidence for intramolecular hydrophobic association in aqueous solution for pyrene-end-capped poly(ethylene oxide)

  1992cited by this paper
• NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat.

  1991cited by this paper
• Effect of urea on micellar properties of aqueous solutions of nonionic surfactants

  1991cited by this paper
• Fluorescence quenching and excimer formation to probe the micellization of a poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer, as modulated by potassium fluoride in aqueous solution

  1991cited by this paper
• Rationale and applications for macromolecular Gd‐based contrast agents

  1991cited by this paper
• Field-cycling relaxometry of protein solutions and tissue: Implications for MRI

  1990cited by this paper
• Polymeric contrast agents for magnetic resonance imaging: synthesis and characterization of gadolinium diethylenetriaminepentaacetic acid conjugated to polysaccharides.

  1990cited by this paper
• CRC Handbook of Chemistry and Physics

  1990cited by this paper
• Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter

  1990cited by this paper
• Anomalous micellization behavior and composition heterogeneity of a triblock ABA copolymer of (A) ethylene oxide and (B) propylene oxide in aqueous solution

  1988cited by this paper
• 1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein‐chelate conjugates

  1986cited by this paper
• Urolithiasis in rats with diabetes insipidus (Brattleboro strain rats).

  1982cited by this paper
• Principles of colloid and surface chemistry

  1977cited by this paper
• Isothermal Unfolding of Globular Proteins in Aqueous Urea Solutions

  1964cited by this paper
• Relaxation Effects in Nuclear Magnetic Resonance Absorption

  1948cited by this paper

• Trinuclear Gd(III) Metal Complex with Amide Core Display Remarkable Enhancement in Relaxivity

  2017cites this paper
• Stimuli-responsive amphiphilic peptides for biomedical applications

  2016cites this paper
• Nanoparticle-based highly sensitive MRI contrast agents with enhanced relaxivity in reductive milieu.

  2016cites this paper
• MRI with Gadolinium‐Based Nanoparticles

  2015cites this paper
• An Asymmetrical Polymer Vesicle Strategy for Significantly Improving T1 MRI Sensitivity and Cancer-Targeted Drug Delivery

  2015cites this paper
• Design of ProCAs (Protein‐Based Gd3+ MRI Contrast Agents) with High Dose Efficiency and Capability for Molecular Imaging of Cancer Biomarkers

  2014cites this paper
• Dendrimers for biomedical applications

  2014cites this paper
• Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents

  2013cites this paper
• Design of novel protein-based MRI contrast agernets with high relaxivity and stabilty for biomedical imaging

  2013cites this paper
• Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

  2012cites this paper
• Dendritic MRI contrast agents: an efficient prelabeling approach based on CuAAC.

  2011cites this paper
• Poly(para-phenylene ethynylene)s functionalized with Gd(III) chelates as potential MRI contrast agents

  2011cites this paper
• Gadolinium-Based Bionanomaterials for Magnetic Resonance Imaging

  2011cites this paper
• Molecular imaging contrast media for visualization of liver function.

  2010cites this paper
• Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

  2010cites this paper
• Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.

  2010cites this paper
• Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.

  2010cites this paper
• Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.

  2010cites this paper
• A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives.

  2009cites this paper
• Gd ( III )-EPTPAC 16 , a new self-assembling potential liver MRI contrast agent : in vitro characterization and in vivo animal imaging studies y

  2008cites this paper
• Gd(III)‐EPTPAC16, a new self‐assembling potential liver MRI contrast agent: in vitro characterization and in vivo animal imaging studies

  2008cites this paper
• Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential

  2007cites this paper
• Relaxation of protons by radicals in rotationally immobilized proteins.

  2007cites this paper
• Modification of Gd‐DTPA cystine copolymers with PEG‐1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography

  2007cites this paper
• Synthesis of pyridine-based polyaminocarboxylic ligands bearing a thioalkyl anchor

  2007cites this paper
• Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents

  2006cites this paper
• [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine].

  2006cites this paper
• Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.

  2006cites this paper
• Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI.

  2005cites this paper
• Focal‐point anchoring: Large proton relaxivity observed for gadolinium‐cored dendrimer complexes in water

  2004cites this paper
• Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI

  2004cites this paper
• Modélisation de la perfusion quantitative en imagerie par résonance magnétique (IRM) cardiaque in-vivo

  2004cites this paper
• MR urography today

  2003cites this paper
• The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent.

  2002cites this paper
• Magnetic resonance imaging contrast agents: Theory and the role of dendrimers

  2002cites this paper
• The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

  2002cites this paper
• Macrocyclic and polymeric lanthanide chelates: from physico-chemical studies to biomedical applications

  2002cites this paper
• Lanthanide-containing liquid crystals and surfactants.

  2002cites this paper
• How does internal motion influence the relaxation of the water protons in Ln(III)DOTA-like complexes?

  2002cites this paper
• The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities.

  2001cites this paper
• Lipari-Szabo approach as a tool for the analysis of macromolecular gadolinium(III)-based MRI contrast agents illustrated by the [Gd(EGTA-BA-(CH2)12)]nn+ polymer

  2001cites this paper
• Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates.

  2001cites this paper
• Targeted Molecular Imaging in Oncology

  2001influential citation
• Polymer-Based Compounds for Targeted Imaging

  2001cites this paper
• Dendrimers in Diagnostics

  2000cites this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cites this paper
• NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.

  1999cites this paper
• Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates

  1999cites this paper
• Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

  1999cites this paper
• Gadolinium-containing copolymeric chelates—a new potential MR contrast agent

  1999cites this paper
• Blood-pool contrast agents for MRI: a critical evaluation.

  1998cites this paper
• Phantom standards with temperature- and field-independent relaxation rates for magnetic resonance imaging.

  1998cites this paper
• Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.

  1998cites this paper